Clinical trial
FMT in Triple Negative Breast Cancer Guided by ctDNA
NCT07292142 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FMT in Triple Negative Breast Cancer Guided by ctDNA
- Lead sponsor
- Jewish General Hospital
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- December 31, 2031
- Enrollment
- 125 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer